Certolizumab pegol Recruiting Phase N/A Trials for Cardiovascular Disease (CVD) / Rheumatoid Arthritis Prevention

IndicationsStatusPurposePhase
RecruitingPreventionNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02714881Lipids, Inflammation, and CV Risk in RA